Literature DB >> 4608

Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.

M Zatz, J W Kebabian, J A Romero, R J Lefkowitz, J Axelrod.   

Abstract

3H-l-Alprenolol, a potent competitive beta adrenergic antagonist, binds to sites in rat pineal gland membranes. The properties of these binding sites were compared to those of the receptors which mediate the beta adrenergic activation of pineal adenylate cyclase. Both sites are highly stereospecific. The l-stereoisomers of alprenolol and propranolol were at least two orders of magnitude more potent than the d-stereoisomers in inhibiting isoproterenol-stimulated adenylate cyclase or 3H-l-alprenolol binding. The dissociation constants (Kd) of the l-stereoisomers of both alprenolol and propranolol were 10 to 22 nM as determined by competition for binding sites or by inhibition of isoproternol-stimulated adenylate cyclase. Beta adrenergic agonists which stimulated adenylate cyclase also competitively inhibited the binding of 3H-l-alprenolol. They showed the same order of potency (isoproterenol greater than norepinephrine greater than or equal to epinephrine) and the same individual affinities in the two systems. Alpha adrenergic blockers were ineffective in inhibiting either adenylate cyclase stimulation or 3H-l-alprenolol binding. Isoproternol stimulation of adenylate cyclase acrivity, and 3H-l-alprenolol binding, were rapid and rapidly reversible. The 3H-l-alprenolol binding sites were saturable and bound 0.6 pmol of ligand per mg of added protein. The data suggest that the binding of 3H-l-alprenolol occurs at sites indistinguishable from the pineal beta adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4608

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Identification and quantification of beta-adrenoceptors sites in red blood cells from rats.

Authors:  G Kaiser; G Wiemer; G Kremer; J Dietz; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

2.  The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal.

Authors:  P J Cowen; S Fraser; D G Grahame-Smith; A R Green; C Stanford
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

3.  Postsynaptic alpha-adrenergic receptors potentiate the beta-adrenergic stimulation of pineal serotonin N-acetyltransferase.

Authors:  D C Klein; D Sugden; J L Weller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Atenolol reduces plasma melatonin concentration in man.

Authors:  P J Cowen; S Fraser; R Sammons; A R Green
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

5.  Catecholamine binding to the beta-adrenergic receptor.

Authors:  R J Lefkowitz; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.

Authors:  L T Williams; T B Gore; R J Lefkowitz
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

Review 7.  Circadian variations of adrenergic receptors in the mammalian pineal gland: a review.

Authors:  B Pangerl; A Pangerl; R J Reiter
Journal:  J Neural Transm Gen Sect       Date:  1990

8.  Hormone-receptor interactions are noncooperative: application to the beta-adrenergic receptor.

Authors:  R J Pollet; M L Standaert; B A Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Analysis of the beta 1 and beta 2 adrenoceptor interactions of the partial agonist, clenbuterol (NAB365), in the rat jugular vein and atria.

Authors:  M L Cohen; K S Wiley; K G Bemis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

10.  Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.

Authors:  S A Checkley; C Thompson; S Burton; C Franey; J Arendt
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.